Immediate Management: Vitamin K Deficiency Bleeding Until Proven Otherwise
A 2-day-old female newborn with grossly deranged PT and aPTT should be immediately treated with intravenous vitamin K (0.5-1 mg) and fresh frozen plasma (10-20 mL/kg) to prevent life-threatening hemorrhage, as this presentation is most consistent with vitamin K deficiency bleeding (VKDB) until proven otherwise.
Initial Emergency Management
The priority is to prevent catastrophic intracranial hemorrhage, which can occur rapidly in untreated VKDB 1. This condition remains a preventable cause of fatal bleeding in early infancy, particularly when prophylactic vitamin K was not administered at birth.
Immediate Actions:
- Administer IV vitamin K immediately (0.5-1 mg for neonates) - do not wait for confirmatory testing 2
- Give fresh frozen plasma 10-20 mL/kg every 12 hours until coagulation parameters normalize 2
- Assess for active bleeding, particularly:
Diagnostic Workup
While treatment is initiated, obtain:
- Coagulation factor assays - specifically factors II, VII, IX, X (vitamin K-dependent factors)
- Factor VIII, IX, XI, XII levels to exclude hemophilia 5, 4
- Fibrinogen and antithrombin levels 6
- Mixing studies - if aPTT corrects with normal plasma, suggests factor deficiency rather than inhibitor 4
- Confirm vitamin K administration history at birth
Key Diagnostic Considerations:
Vitamin K deficiency presents with:
- Prolonged PT and aPTT (both affected)
- Normal fibrinogen
- Low factors II, VII, IX, X
- Responds rapidly to vitamin K administration
Hemophilia A (factor VIII deficiency) presents with:
- Isolated aPTT prolongation (PT normal)
- Factor VIII activity <1% in severe cases 5, 4
- Does NOT respond to vitamin K
- May present with cephalohematoma or ecchymoses in neonatal period
Factor X deficiency presents with:
- Both PT and aPTT prolonged
- Requires specific factor X assay for diagnosis 3
- Often misdiagnosed as VKDB
Common Pitfalls to Avoid
Do not delay treatment waiting for factor assays - the risk of intracranial hemorrhage is immediate and potentially fatal 1
Do not assume vitamin K was given - verify administration history, as parental refusal or documentation errors occur 1
Do not use IM injections for vitamin K in a coagulopathic neonate - use IV route to avoid hematoma formation
Do not miss congenital coagulopathies - if no response to vitamin K within 6-12 hours, strongly consider hemophilia or other inherited factor deficiencies 5, 4
Response Assessment and Next Steps
If coagulation normalizes within 12-24 hours:
- Diagnosis confirmed as VKDB
- Complete vitamin K course
- Investigate why prophylaxis was missed
- Ensure adequate vitamin K stores before discharge
If no improvement after vitamin K and FFP:
- Suspect congenital factor deficiency (hemophilia A most common) 5, 4
- Review factor assay results
- Consider genetic testing if factor VIII <1% (intron 22 inversion most common in severe hemophilia A) 4
- Initiate factor replacement therapy or consider emicizumab for hemophilia A 5, 4
- Arrange hematology consultation
For confirmed severe hemophilia A:
- Prophylactic emicizumab has shown excellent outcomes in neonatal cases 5, 4
- Avoid IM injections and invasive procedures
- Genetic counseling for family
Special Consideration: Cholestatic Liver Disease
If jaundice is prominent, consider neonatal intrahepatic cholestasis (e.g., citrin deficiency), which causes:
- Prolonged PT/aPTT from malabsorption of vitamin K
- Low fibrinogen and antithrombin (unlike typical VKDB) 6
- Requires nutritional management with medium-chain triglycerides in addition to vitamin K
The hemostatic rebalancing in cholestatic disease means these infants may not bleed despite abnormal labs, but vitamin K supplementation is still essential 6.